Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2019 Sep 20;18(8):1760–1768.e1. doi: 10.1016/j.cgh.2019.09.021

Figure 3.

Figure 3.

Change in rectal bleeding (RB) and stool frequency (SF) at week 8 after treatment with 3.2g mesalazine compared to change in Mayo endoscopic subscore (MES).